MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
for Lumbar Spinal Stenosis
Sites in Manchester, Bedford +2366 more locations
Sponsor: Stryker Instruments
Sex: All·Age: 18+
Code: NCT03072927·Recruiting·Listed Mar 2017
Paid Clinical Trials in Manchester, NH
As of August 2026, 31 paid clinical trials are recruiting in Manchester, New Hampshire. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Manchester offers studies at sites including Solinsky Center for Cancer Care for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Manchester
Trials by drug in Manchester
Filter results
Filter results
30 clinical trials
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
for Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Drug: Navlimetostat
Sites in Manchester, Lebanon +32 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07063745·Phase 2, Phase 3·Recruiting·Listed Jul 2025
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
for Aortic Stenosis
Sites in Manchester, Lebanon +69 more locations
Sponsor: Medtronic Cardiovascular
Sex: All·Age: 18 - 105
Code: NCT06777368·Recruiting·Listed Jan 2025
A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves
for Post Operative Pain
Sites in Manchester +5 more locations
Sponsor: AtriCure, Inc.
Sex: All·Age: 12+
Code: NCT05110989·Recruiting·Listed Nov 2021
Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain
for Amputation
Sites in Manchester +4 more locations
Sponsor: AtriCure, Inc.
Sex: All·Age: 18+
Code: NCT06908538·Recruiting·Listed Apr 2025
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
for Lung Non-Small Cell Carcinoma
Sites in Manchester, Concord +633 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT04267848·Phase 3·Recruiting·Listed Feb 2020
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
for Stage III Colon Cancer
Sites in Manchester, Londonderry +913 more locations
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT05174169·Phase 2, Phase 3·Recruiting·Listed Dec 2021
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
for Anatomic Stage II Breast Cancer AJCC v8
Sites in Manchester, Londonderry +777 more locations
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 18+
Code: NCT05812807·Phase 3·Recruiting·Listed Apr 2023
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for Anatomic Stage I Breast Cancer AJCC v8
Sites in Manchester, Concord +591 more locations
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 18+
Code: NCT06876714·Phase 3·Recruiting·Listed Mar 2025
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
for Acute Lymphoblastic Leukemia
Sites in Manchester, Concord +616 more locations
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 40 - 75·Accepts healthy volunteers
Code: NCT05334069·Recruiting·Listed Apr 2022
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
for Resectable Lung Non-Small Cell Carcinoma
Sites in Manchester, Nashua +325 more locations
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 18+
Code: NCT06632327·Phase 3·Recruiting·Listed Oct 2024
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
for Previously Treated Non-Small Cell Lung Cancer
Sites in Manchester, Nashua +948 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18+
Code: NCT03851445·Phase 2, Phase 3·Recruiting·Listed Feb 2019
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
for Recurrent Lung Non-Small Cell Carcinoma
Sites in Manchester, Concord +370 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18+
Code: NCT05642572·Phase 2·Recruiting·Listed Dec 2022
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
for Lymphoma, Non-Hodgkin
Sites in Manchester, Concord +144 more locations
Sponsor: American Society of Clinical Oncology
Sex: All·Age: 12+
Code: NCT02693535·Phase 2·Recruiting·Listed Feb 2016
ATEMPT 2.0: Adjuvant T-DM1 vs TH
for Breast Cancer
Sites in Manchester, Londonderry +44 more locations
Sponsor: Dana-Farber Cancer Institute
Sex: All·Age: 18+
Code: NCT04893109·Phase 2·Recruiting·Listed May 2021
Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean Diet
for Cystic Fibrosis (CF)
Sites in Manchester & Lebanon
Sponsor: Dartmouth-Hitchcock Medical Center
Sex: All·Age: 3 - 18
Code: NCT07223255·Recruiting·Listed Oct 2025
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for Recurrent Lung Non-Small Cell Carcinoma
Drug: Cemiplimab
Sites in Manchester, Concord +379 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18+
Code: NCT06616584·Phase 2, Phase 3·Recruiting·Listed Sep 2024
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
for Recurrent Lung Non-Small Cell Carcinoma
Sites in Manchester, Concord +239 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18 Minutes+
Code: NCT06031688·Phase 2·Recruiting·Listed Sep 2023
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
for Anatomic Stage IV Breast Cancer AJCC v8
Sites in Manchester, Concord +584 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18+
Code: NCT03723928·Recruiting·Listed Oct 2018
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
for Lung Non-Small Cell Carcinoma
Sites in Manchester, Concord +241 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18+
Code: NCT06116682·Phase 2·Recruiting·Listed Nov 2023
Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients
for Anxiety Disorders
Sites in Manchester, Nashua +4 more locations
Sponsor: Dartmouth-Hitchcock Medical Center
Sex: All·Age: 18 - 100
Code: NCT06898593·Recruiting·Listed Mar 2025
I-DECIDE After Bronchiolitis Hospitalization
for Bronchiolitis Acute
Sites in Manchester +55 more locations
Sponsor: Seattle Children's Hospital
Sex: All·Age: 0 Months - 24 Months
Code: NCT07243652·Recruiting·Listed Nov 2025
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
for Diabetes Mellitus
Sites in Manchester +2 more locations
Sponsor: Dartmouth-Hitchcock Medical Center
Sex: All·Age: 18+
Code: NCT05955339·Recruiting·Listed Jul 2023
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
for Advanced Cancer
Sites in Manchester, Concord +4 more locations
Sponsor: Alliance Foundation Trials, LLC.
Sex: All·Age: 21+
Code: NCT06963723·Recruiting·Listed May 2025
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
for Anatomic Stage I Breast Cancer AJCC v8
Sites in Manchester, Concord +913 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18+
Code: NCT05929768·Phase 3·Recruiting·Listed Jul 2023
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
for Castration Levels of Testosterone
Sites in Manchester, Concord +292 more locations
Sponsor: SWOG Cancer Research Network
Sex: Male·Age: 18+
Code: NCT03678025·Phase 3·Recruiting·Listed Sep 2018
Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer
for Ovarian Cancer
Sites in Manchester & Lebanon
Sponsor: Tyler J Curiel
Sex: Female·Age: 18+
Code: NCT06815497·Phase 2·Recruiting·Listed Feb 2025
The HALT Biomarker Study
for Aortic Stenosis
Sites in Manchester +2 more locations
Sponsor: Massachusetts General Hospital
Sex: All·Age: 65+
Code: NCT04552275·Phase 1·Recruiting·Listed Sep 2020
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
for Growth Hormone Deficiency
Sites in Manchester, Lebanon +25 more locations
Sponsor: Ascendis Pharma Endocrinology Division A/S
Sex: All·Age: All ages
Code: NCT05820672·Recruiting·Listed Apr 2023
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
for Growth Hormone Deficiency
Sites in Manchester, Lebanon +25 more locations
Sponsor: Ascendis Pharma Endocrinology Division A/S
Sex: All·Age: 1 - 18
Code: NCT05775523·Recruiting·Listed Mar 2023
Top Research Study Locations in Manchester
Researchers run research studies in Manchester, NH at 13 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Solinsky Center for Cancer Care | Anatomic Stage II Breast Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | 15 |
| Catholic Medical Center | Aortic Stenosis, Bioprosthetic Valve Degeneration, Hypo-attenuated Leaflet Thickening | 3 |
| Elliot Hospital | Amputation, Amputation of Lower Limb, Amputation of Upper Limb | 3 |
| Ascendis Investigational Site | Growth Hormone Deficiency | 2 |
| Dartmouth Cancer Center - Manchester/ DCC Manchester | Previously Treated Non-Small Cell Lung Cancer, Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 | 2 |
| Children's Hospital at Dartmouth-Hitchcock | Bronchiolitis Acute | 1 |
| Dartmouth Health Children's | Cystic Fibrosis (CF), Cystic Fibrosis Gastrointestinal Disease | 1 |
| Dartmouth Hitchcock Clinics Manchester | Diabetes Mellitus, Hypertension | 1 |
| Dartmouth Hitchcock Manchester Family Practice | Anxiety Disorders, Depression Disorders | 1 |
| Dartmouth Hitchcock medical center | Parkinson Disease | 1 |
| Dartmouth-Hitchcock Manchester | Ovarian Cancer | 1 |
| Local Institution - 0600 | Metastatic Non-small Cell Lung Cancer With MTAP Deletion | 1 |
| Solinsky Center for Cancer Care (NH Oncology-Hematology, PA) | Breast Cancer, HER2-positive Breast Cancer | 1 |
Active & Upcoming Studies in Manchester (2026)
Recruiting trials in Manchester grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (19 active studies)
- Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer · Phase 2 · Tyler J Curiel
- A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion · Phase 2, Phase 3 · Bristol-Myers Squibb
Neurology & pain (2 active studies)
Mental health & behavior (1 active study)
- Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients · Dartmouth-Hitchcock Medical Center
Diabetes & metabolic (1 active study)
- Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults · Dartmouth-Hitchcock Medical Center
Cardiovascular (1 active study)
- Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults · Dartmouth-Hitchcock Medical Center
Common conditions studied in Manchester
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Recurrent Lung Non-Small Cell Carcinoma (3 active studies)
- Stage IV Lung Cancer AJCC v8 (3 active studies)
- Anatomic Stage I Breast Cancer AJCC v8 (2 active studies)
- Anatomic Stage IIIA Breast Cancer AJCC v8 (2 active studies)
- Anatomic Stage IIIB Breast Cancer AJCC v8 (2 active studies)
Leading research sponsors in Manchester
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- Dartmouth-Hitchcock Medical Center
- Ascendis Pharma Endocrinology Division A/S
- AtriCure, Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Manchester?
There are approximately 31 recruiting clinical trials in Manchester, New Hampshire listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Manchester pay participants?
Most recruiting trials in Manchester compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Manchester?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Manchester?
The most common conditions under active study in Manchester include Anatomic Stage II Breast Cancer AJCC v8 (3), Recurrent Lung Non-Small Cell Carcinoma (3), Stage IV Lung Cancer AJCC v8 (3), Anatomic Stage I Breast Cancer AJCC v8 (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Manchester?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Manchester on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Manchester?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Manchester?
Recruiting research sites in Manchester include Solinsky Center for Cancer Care, Catholic Medical Center, Elliot Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Manchester right now?
The largest active categories in Manchester are Cancer & tumors (19), Neurology & pain (2), Mental health & behavior (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.